Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus + Rituximab in R/R DLBCL
NCT00869999Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- May 2009
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in diffuse large B-cell lymphoma (DLBCL), sponsored by Massachusetts General Hospital. Started May 2009; status: completed.
02
Drugs
everolimus
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00869999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00869999.